vs

Side-by-side financial comparison of Roivant Sciences Ltd. (ROIV) and WRAP TECHNOLOGIES, INC. (WRAP). Click either name above to swap in a different company.

Roivant Sciences Ltd. is the larger business by last-quarter revenue ($2.0M vs $1.4M, roughly 1.4× WRAP TECHNOLOGIES, INC.). WRAP TECHNOLOGIES, INC. runs the higher net margin — -280.9% vs -13301.2%, a 13020.3% gap on every dollar of revenue. On growth, WRAP TECHNOLOGIES, INC. posted the faster year-over-year revenue change (62.3% vs -77.8%). WRAP TECHNOLOGIES, INC. produced more free cash flow last quarter ($-2.7M vs $-201.4M). Over the past eight quarters, WRAP TECHNOLOGIES, INC.'s revenue compounded faster (-2.5% CAGR vs -73.7%).

Roivant Sciences Ltd. is an American multinational healthcare company focused on applying technology to drug development and building subsidiary life sciences and health technology companies. It was founded in 2014 by Vivek Ramaswamy and is currently headed by CEO Matt Gline. Roivant maintains its headquarters in New York City as well as major offices in the biotech hubs of Boston and Basel.

Wrap Technologies, Inc. develops non-lethal safety solutions for law enforcement, corrections, and private security sectors across North America and global markets. Its core products include remote restraint devices and training services designed to reduce use-of-force injuries and improve public safety outcomes.

ROIV vs WRAP — Head-to-Head

Bigger by revenue
ROIV
ROIV
1.4× larger
ROIV
$2.0M
$1.4M
WRAP
Growing faster (revenue YoY)
WRAP
WRAP
+140.1% gap
WRAP
62.3%
-77.8%
ROIV
Higher net margin
WRAP
WRAP
13020.3% more per $
WRAP
-280.9%
-13301.2%
ROIV
More free cash flow
WRAP
WRAP
$198.7M more FCF
WRAP
$-2.7M
$-201.4M
ROIV
Faster 2-yr revenue CAGR
WRAP
WRAP
Annualised
WRAP
-2.5%
-73.7%
ROIV

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
ROIV
ROIV
WRAP
WRAP
Revenue
$2.0M
$1.4M
Net Profit
$-265.9M
$-3.9M
Gross Margin
52.3%
Operating Margin
-16966.1%
-281.1%
Net Margin
-13301.2%
-280.9%
Revenue YoY
-77.8%
62.3%
Net Profit YoY
-257.0%
48.1%
EPS (diluted)
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ROIV
ROIV
WRAP
WRAP
Q4 25
$2.0M
$1.4M
Q3 25
$1.6M
$1.5M
Q2 25
$2.2M
$1.0M
Q1 25
$-39.6M
$765.0K
Q4 24
$9.0M
$865.0K
Q3 24
$4.5M
$593.0K
Q2 24
$8.0M
$1.6M
Q1 24
$28.9M
$1.5M
Net Profit
ROIV
ROIV
WRAP
WRAP
Q4 25
$-265.9M
$-3.9M
Q3 25
$-113.5M
$-2.8M
Q2 25
$-223.4M
$-3.7M
Q1 25
$-206.5M
$109.0K
Q4 24
$169.4M
$-7.6M
Q3 24
$-230.2M
$2.0M
Q2 24
$95.3M
$-385.0K
Q1 24
$-151.1M
$117.0K
Gross Margin
ROIV
ROIV
WRAP
WRAP
Q4 25
52.3%
Q3 25
59.2%
Q2 25
48.1%
Q1 25
77.8%
Q4 24
47.4%
Q3 24
39.6%
Q2 24
62.6%
Q1 24
56.6%
Operating Margin
ROIV
ROIV
WRAP
WRAP
Q4 25
-16966.1%
-281.1%
Q3 25
-19492.9%
-185.2%
Q2 25
-13130.0%
-282.2%
Q1 25
674.8%
-512.7%
Q4 24
-3042.6%
-535.5%
Q3 24
-7636.0%
-611.5%
Q2 24
-1279.5%
-201.5%
Q1 24
-919.5%
-280.4%
Net Margin
ROIV
ROIV
WRAP
WRAP
Q4 25
-13301.2%
-280.9%
Q3 25
-7225.9%
-186.0%
Q2 25
-10292.9%
-368.3%
Q1 25
521.8%
14.2%
Q4 24
1878.3%
-878.3%
Q3 24
-5143.8%
335.6%
Q2 24
1192.7%
-24.5%
Q1 24
-522.3%
7.9%
EPS (diluted)
ROIV
ROIV
WRAP
WRAP
Q4 25
$-0.38
Q3 25
$-0.17
$-0.06
Q2 25
$-0.33
$-0.07
Q1 25
$-0.28
Q4 24
$0.23
Q3 24
$-0.31
$0.04
Q2 24
$0.12
$-0.02
Q1 24
$-0.02

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ROIV
ROIV
WRAP
WRAP
Cash + ST InvestmentsLiquidity on hand
$4.5B
$3.5M
Total DebtLower is stronger
Stockholders' EquityBook value
$4.3B
$11.5M
Total Assets
$5.2B
$15.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ROIV
ROIV
WRAP
WRAP
Q4 25
$4.5B
$3.5M
Q3 25
$4.4B
$6.0M
Q2 25
$4.5B
$4.2M
Q1 25
$4.9B
$6.2M
Q4 24
$5.1B
$3.6M
Q3 24
$5.4B
$4.9M
Q2 24
$5.7B
$4.6M
Q1 24
$6.5B
$8.2M
Total Debt
ROIV
ROIV
WRAP
WRAP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
$311.7M
Q1 24
$430.6M
Stockholders' Equity
ROIV
ROIV
WRAP
WRAP
Q4 25
$4.3B
$11.5M
Q3 25
$4.4B
$14.1M
Q2 25
$4.3B
$11.8M
Q1 25
$4.7B
$2.6M
Q4 24
$5.2B
$250.0K
Q3 24
$5.2B
$6.4M
Q2 24
$5.4B
$3.8M
Q1 24
$6.0B
$4.5M
Total Assets
ROIV
ROIV
WRAP
WRAP
Q4 25
$5.2B
$15.4M
Q3 25
$5.1B
$18.2M
Q2 25
$5.0B
$15.6M
Q1 25
$5.4B
$18.0M
Q4 24
$5.8B
$15.1M
Q3 24
$6.2B
$18.8M
Q2 24
$6.5B
$21.8M
Q1 24
$7.2B
$24.8M
Debt / Equity
ROIV
ROIV
WRAP
WRAP
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
0.06×
Q1 24
0.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ROIV
ROIV
WRAP
WRAP
Operating Cash FlowLast quarter
$-196.5M
$-2.7M
Free Cash FlowOCF − Capex
$-201.4M
$-2.7M
FCF MarginFCF / Revenue
-10076.0%
-190.3%
Capex IntensityCapex / Revenue
246.9%
0.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-776.7M
$-10.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ROIV
ROIV
WRAP
WRAP
Q4 25
$-196.5M
$-2.7M
Q3 25
$-185.7M
$-2.6M
Q2 25
$-204.4M
$-1.9M
Q1 25
$-172.6M
$-3.1M
Q4 24
$-207.3M
$-1.2M
Q3 24
$-266.8M
$330.0K
Q2 24
$-192.8M
$-3.5M
Q1 24
$-108.5M
$-3.7M
Free Cash Flow
ROIV
ROIV
WRAP
WRAP
Q4 25
$-201.4M
$-2.7M
Q3 25
$-193.5M
$-2.7M
Q2 25
$-208.4M
$-1.9M
Q1 25
$-173.4M
$-3.1M
Q4 24
$-209.1M
$-1.2M
Q3 24
$-267.8M
Q2 24
$-193.8M
$-3.5M
Q1 24
$-108.8M
$-3.7M
FCF Margin
ROIV
ROIV
WRAP
WRAP
Q4 25
-10076.0%
-190.3%
Q3 25
-12317.8%
-181.1%
Q2 25
-9604.5%
-192.3%
Q1 25
438.1%
-401.4%
Q4 24
-2318.5%
-139.5%
Q3 24
-5984.4%
Q2 24
-2425.5%
-224.2%
Q1 24
-376.1%
-253.3%
Capex Intensity
ROIV
ROIV
WRAP
WRAP
Q4 25
246.9%
0.5%
Q3 25
499.6%
5.7%
Q2 25
185.9%
0.6%
Q1 25
-2.0%
0.3%
Q4 24
20.3%
0.1%
Q3 24
22.3%
0.0%
Q2 24
12.1%
0.1%
Q1 24
1.2%
0.9%
Cash Conversion
ROIV
ROIV
WRAP
WRAP
Q4 25
Q3 25
Q2 25
Q1 25
-28.16×
Q4 24
-1.22×
Q3 24
0.17×
Q2 24
-2.02×
Q1 24
-31.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons